NO
Last reporting period 30 Jun, 2024
Updated —
Last price
—
Market cap $B
64.868
Exchange
XDUS - Boerse Duesseldorf
28 %
Last period Growth rate volatility (2y)
23%
Growth rate volatility (2y) has increased in 5 years
What is Growth rate volatility (2y) ?
An indicator of the degree of volatility in the growth rate of a company's profit in the medium-term retrospective. A value below the average growth rate for the same period is the benchmark for calculating a company rating in Eyestock model.
See also Novo Nordisk
Company Analysis
NOVC.DU valuation, rating, competitors, insights and company profile
Eyestock Rating
NOVC.DU financial analysis by Eyestock methodology
Valuation
NOVC.DU valuation using historical relative method
Statements
NOVC.DU Income Statements, Balance Sheet and Cash Flow Statements
Dividends
NOVC.DU dividend yield and annual dividend
An indicator of the degree of volatility in the growth rate of a company's profit in the medium-term retrospective. A value below the average growth rate for the same period is the benchmark for calculating a company rating in Eyestock model.
Novo Nordisk`s Growth rate volatility (2y) for the period ended 2024-06-30 is 28 %
